• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting Intravenous Immunoglobulin Resistance Among North American Children Hospitalized With Kawasaki Disease.预测北美住院川崎病患儿对静脉注射免疫球蛋白的抵抗情况。
J Pediatr Pharmacol Ther. 2022;27(7):669-676. doi: 10.5863/1551-6776-27.7.669. Epub 2022 Sep 26.
2
Evaluating the performance of egami, kobayashi and sano scores in predicting IVIG resistance in infant kawasaki disease.评估 egami、小林和佐野评分在预测婴儿川崎病 IVIG 抵抗中的表现。
BMC Pediatr. 2024 Sep 28;24(1):606. doi: 10.1186/s12887-024-05035-z.
3
Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.亚洲风险评分系统无法预测意大利队列川崎病患者静脉注射免疫球蛋白耐药和冠状动脉病变。
Eur J Pediatr. 2019 Mar;178(3):315-322. doi: 10.1007/s00431-018-3297-5. Epub 2018 Nov 29.
4
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉瘤的预测因素
Paediatr Int Child Health. 2018 Aug;38(3):209-212. doi: 10.1080/20469047.2018.1471381. Epub 2018 May 17.
5
Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study.中国川崎病儿科人群中静脉注射免疫球蛋白治疗抵抗和冠状动脉异常的危险因素:一项回顾性队列研究
Front Pediatr. 2022 Apr 20;10:812644. doi: 10.3389/fped.2022.812644. eCollection 2022.
6
Predicting IVIG resistance in UK Kawasaki disease.预测英国川崎病患者对静脉注射免疫球蛋白的耐药性。
Arch Dis Child. 2015 Apr;100(4):366-8. doi: 10.1136/archdischild-2014-307397. Epub 2015 Feb 10.
7
Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.川崎病患儿免疫球蛋白抵抗及冠状动脉并发症的危险因素
Kardiol Pol. 2017;75(3):261-266. doi: 10.5603/KP.a2016.0179. Epub 2016 Dec 20.
8
Risk factors in IVIG-resistant Kawasaki disease and correlation with Japanese scoring systems - a study from Eastern India.静脉注射免疫球蛋白抵抗型川崎病的危险因素及其与日本评分系统的相关性——一项来自印度东部的研究
Clin Rheumatol. 2023 Jan;42(1):145-150. doi: 10.1007/s10067-022-06344-3. Epub 2022 Sep 2.
9
The factors affecting the disease course in Kawasaki disease.影响川崎病病程的因素。
Rheumatol Int. 2019 Aug;39(8):1343-1349. doi: 10.1007/s00296-019-04336-2. Epub 2019 May 28.
10
A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.一种用于预测1岁以下婴儿川崎病静脉注射免疫球蛋白耐药性的新评分系统。
Front Pediatr. 2019 Dec 11;7:514. doi: 10.3389/fped.2019.00514. eCollection 2019.

引用本文的文献

1
Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.营养相关生物标志物在预测川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变中的作用:一项系统评价和荟萃分析
Food Sci Nutr. 2024 Dec 15;13(1):e4647. doi: 10.1002/fsn3.4647. eCollection 2025 Jan.

本文引用的文献

1
Kawasaki Disease: an Update.川崎病:最新进展。
Curr Rheumatol Rep. 2020 Sep 13;22(10):75. doi: 10.1007/s11926-020-00941-4.
2
A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.基于中国东南人群的机器学习方法预测川崎病患儿静脉注射免疫球蛋白抵抗:一项研究。
PLoS One. 2020 Aug 27;15(8):e0237321. doi: 10.1371/journal.pone.0237321. eCollection 2020.
3
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.预测儿童川崎病的静脉注射免疫球蛋白耐药性。
World J Pediatr. 2020 Dec;16(6):607-613. doi: 10.1007/s12519-020-00348-2. Epub 2020 Mar 30.
4
Spatiotemporal Analysis and Epidemiology of Kawasaki Disease in Western New York: A 16-Year Review of Cases Presenting to a Single Tertiary Care Center.纽约西部川崎病的时空分析和流行病学:一家三级保健中心 16 年的病例报告。
Pediatr Infect Dis J. 2019 Jun;38(6):582-588. doi: 10.1097/INF.0000000000002239.
5
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
6
Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease.川崎病患儿静脉注射免疫球蛋白耐药的预测。
J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):25-29. doi: 10.1093/jpids/piw075.
7
Kawasaki disease in infants below 6 months: a clinical conundrum?6个月以下婴儿的川崎病:一个临床难题?
Int J Rheum Dis. 2016 Sep;19(9):924-8. doi: 10.1111/1756-185X.12854. Epub 2016 Mar 16.
8
Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白治疗耐药性预测因素的荟萃分析。
Korean J Pediatr. 2016 Feb;59(2):80-90. doi: 10.3345/kjp.2016.59.2.80. Epub 2016 Feb 29.
9
The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis.肝功能异常在川崎病静脉注射免疫球蛋白无反应中的预后作用:一项荟萃分析。
Inflamm Res. 2016 Feb;65(2):161-8. doi: 10.1007/s00011-015-0900-3. Epub 2015 Dec 8.
10
Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database.免疫球蛋白抵抗型川崎病的流行病学:来自一个大型全国数据库的结果
Pediatr Cardiol. 2015 Feb;36(2):374-8. doi: 10.1007/s00246-014-1016-1. Epub 2014 Sep 2.

预测北美住院川崎病患儿对静脉注射免疫球蛋白的抵抗情况。

Predicting Intravenous Immunoglobulin Resistance Among North American Children Hospitalized With Kawasaki Disease.

作者信息

Singh Jasdip, Chang Arthur, Fusco Nicholas M, Hicar Mark

机构信息

Department of Pharmacy Practice (JS, NF), University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY.

Department of Pediatrics (AC, MH), University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY.

出版信息

J Pediatr Pharmacol Ther. 2022;27(7):669-676. doi: 10.5863/1551-6776-27.7.669. Epub 2022 Sep 26.

DOI:10.5863/1551-6776-27.7.669
PMID:36186240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9514769/
Abstract

OBJECTIVE

The Kobayashi score (KS) is the most widely used tool for predicting intravenous immunoglobulin (IVIG) resistance in Kawasaki disease (KD). The KS has shown good sensitivity (86%) and specificity (68%) in Japanese children; however, its use is limited outside of Japan. No models accurately predict IVIG resistance of children with KD in the United States. We sought to develop and test a novel scoring system to predict IVIG resistance in hospitalized children with KD.

METHODS

A retrospective chart review was conducted of all children diagnosed with KD from January 2000 to December 2015. Subjects were divided into 2 groups: IVIG susceptible or resistant. Variables that differed between the groups were identified and used to create a "new score" to predict resistance to IVIG. The new score was then compared with the KS and performance characteristics were determined.

RESULTS

A total of 208 subjects were reviewed. White blood cell count, neutrophil percentage, age, and serum albumin were used in the new score with equal weighting. Overall, the new score achieved improved sensitivity (54% vs 26%) and similar specificity (69% vs 74%) compared with the KS in predicting IVIG resistance in hospitalized children diagnosed with KD.

CONCLUSIONS

Predicting IVIG resistance in children diagnosed with KD remains challenging. The KS has low sensitivity in predicting IVIG resistance in children with KD in the United States. The new score resulted in improved sensitivity, but many children with true IVIG resistance may be missed. Further research is needed to improve IVIG resistance prediction.

摘要

目的

小林评分(KS)是预测川崎病(KD)静脉注射免疫球蛋白(IVIG)抵抗最广泛使用的工具。KS在日本儿童中显示出良好的敏感性(86%)和特异性(68%);然而,其应用在日本以外地区受到限制。在美国,尚无模型能准确预测KD患儿的IVIG抵抗情况。我们试图开发并测试一种新的评分系统,以预测住院KD患儿的IVIG抵抗情况。

方法

对2000年1月至2015年12月期间所有诊断为KD的儿童进行回顾性病历审查。将受试者分为两组:IVIG敏感或抵抗组。确定两组之间存在差异的变量,并用于创建一个“新评分”来预测对IVIG的抵抗。然后将新评分与KS进行比较,并确定其性能特征。

结果

共审查了208名受试者。新评分中使用了白细胞计数、中性粒细胞百分比、年龄和血清白蛋白,权重相等。总体而言,在预测住院KD患儿的IVIG抵抗方面,与KS相比,新评分的敏感性有所提高(54%对26%),特异性相似(69%对74%)。

结论

预测诊断为KD的儿童的IVIG抵抗仍然具有挑战性。KS在美国KD患儿中预测IVIG抵抗的敏感性较低。新评分提高了敏感性,但可能会遗漏许多真正存在IVIG抵抗的儿童。需要进一步研究以改善IVIG抵抗的预测。